Regenosome Forum 2026: Celebrating Two Years of Innovations in Longevity Technology
Regenosome Forum 2026: A Milestone in Longevity Research
On July 24, 2026, Regenosome Inc., a group company of Space Seed Holdings, held the "Regenosome Tech Forum 2026" at THE LINKPILLAR in Tokyo. This event marked the company's two-year anniversary and served as a platform to share research achievements and future plans. The forum comprised four key segments: an overview of research outcomes over the past two years, lightning talks by research partners, a presentation of the business direction for the upcoming year, and a networking reception.
Key Highlights of the Forum
Report on Two Years of Research
CEO Kengo Suzuki presented a comprehensive overview of the company's research milestones. Regenosome has focused on three main aspects to address aging: Measuring, Transporting, and Effecting.
1. Measuring: A novel method was established to predict age through DNA methylation analysis using saliva samples. This technique allows for low-impact testing and has been patented.
2. Transporting: The design of nanoparticles that protect functional ingredients during delivery to targeted areas was highlighted. A collaboration with Tokyo University of Agriculture and Technology resulted in a patent application regarding
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.